Cadaverine Tartrate

Cadaverine Tartrate

SCHEMBL5801090

O=C(O)C(O)C(O)C(=O)O.[Cu].[NaH]

nearest known ligand 0.83

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3CHRM1CHRM2CHRM3CHRM4ESR1ESR2GABRA1GABRB1GABRG2GBA1HRH1HTR1DHTR2AOPRD1OPRK1OPRM1SLC6A2SLC6A3TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8rplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Cadaverine Tartrate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.83
TP53 P04637 1/20 0.44
CYP2C9 P11712 2/20 0.41
PDE4A P27815 1/20 0.41
CYP2C19 P33261 2/20 0.39
NFKB1 P19838 1/20 0.39
LMNA P02545 2/20 0.38
ALDH1A1 P00352 2/20 0.38
THRB P10828 1/20 0.38
RECQL P46063 1/20 0.38
OR51E2 Q9H255 1/20 0.37
HPGD P15428 2/20 0.35
HSD17B10 Q99714 2/20 0.35
TDP1 Q9NUW8 2/20 0.35
ABCB11 O95342 1/20 0.35
F2 P00734 1/20 0.35
KDM4E B2RXH2 1/20 0.35
MEN1 O00255 1/20 0.35
MAPT P10636 1/20 0.35
ALOX15 P16050 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Cadaverine Tartrate SCHEMBL28470658 0.96 TSHR (0.77) TSHRTP53CYP2C9PDE4ACYP2C19
Cadaverine Tartrate SCHEMBL3165960 0.96 TSHR (0.91) TSHRTP53CYP2C9PDE4ACYP2C19
Cadaverine Tartrate SCHEMBL24914 0.96 TSHR (0.91) TSHRTP53CYP2C9PDE4ACYP2C19
Cadaverine Tartrate SCHEMBL29522123 0.96 TSHR (0.91) TSHRTP53CYP2C9PDE4ACYP2C19
Cadaverine Tartrate SCHEMBL3165957 0.96 TSHR (0.91) TSHRTP53CYP2C9PDE4ACYP2C19
Cadaverine Tartrate SCHEMBL25307085 0.96 TSHR (0.91) TSHRTP53CYP2C9PDE4ACYP2C19
Cadaverine Tartrate SCHEMBL14742964 0.96 TSHR (0.91) TSHRTP53CYP2C9PDE4ACYP2C19
Cadaverine Tartrate SCHEMBL119096 0.96 TSHR (0.91) TSHRTP53CYP2C9PDE4ACYP2C19
Cadaverine Tartrate SCHEMBL1764683 0.96 TSHR (0.91) TSHRTP53CYP2C9PDE4ACYP2C19
Cadaverine Tartrate SCHEMBL27709520 0.93 TSHR (0.71) TSHRTP53CYP2C9PDE4ACYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101935275-A Preparation method and application of gum rosin acid copper BO KONG 2011-01-05 CN claimed
CN-108972795-A A method of promoting wicker dye-uptake 阜南县柳祥工艺品有限公司 2018-12-11 CN disclosed
US-20160016116-A1 FORWARD OSMOSIS SYSTEM USING COORDINATION COMPLEXES NATIONAL UNIVERSITY OF SINGAPORE (SG) 2016-01-21 US disclosed
CN-104119403-A Copper zirconium tartrate compound as well as preparation method and use thereof XIAN MODERN CHEMISTRY RES INST 2014-10-29 CN disclosed
WO-2014163589-A1 FORWARD OSMOSIS SYSTEM USING COORDINATION COMPLEXES NATIONAL UNIVERSITY OF SINGAPORE (SG) 2014-10-09 WO disclosed
CN-102719113-B Ink-jet ink with light resistance and preparation method thereof Shanghai waysmos fine chemical co ltd 2014-09-03 CN disclosed
CN-103305022-A Azo type direct dye and preparation method thereof Shanghai waysmos fine chemical co ltd 2013-09-18 CN disclosed
CN-102153884-B Ink-type dye, and preparation method and application thereof LIANYUNGANG QINGTAI CHEMICAL CO LTD 2013-06-19 CN disclosed
CN-102719113-A Ink-jet ink with light resistance and preparation method thereof Shanghai waysmos fine chemical co ltd 2012-10-10 CN disclosed
CN-102153884-A Ink-type dye, and preparation method and application thereof LIANYUNGANG QINGTAI CHEMICAL CO LTD 2011-08-17 CN disclosed
US-6521032-B1 Inks yield magenta prints and dyeings having good fastness to light and high color brilliance CIBA SPECIALTY CHEMICALS CORPORATION 2003-02-18 US disclosed
CN-1101176-C Polyol composition, process for its preparation and its applications ROQUETTE FRERES (FR) 2003-02-12 CN disclosed
US-5773604-A HEAT RESISTANT POLYOLS WITH CHEMICAL STABILITY ROQUETTE FRERES (FR) 1998-06-30 US disclosed
CN-1130502-A Polyol composition, process for its preparation and its applications ROQUETTE FRERES (FR) 1996-09-11 CN disclosed
US-4515599-A COLORFAST BLUE SHADES CIBA GEIGY CORPORATION (US) 1985-05-07 US disclosed
US-4283331-A FIBER-REACTIVE DYES CIBA-GEIGY CORPORATION (US) 1981-08-11 US disclosed
US-4270918-A METALLIZED TRIAZINE-FUNCTIONAL MONOAZO DYE CIBA-GEIGY CORPORATION (US) 1981-06-02 US disclosed
US-4001203-A Heavy metal complexes of azo dyestuffs containing a heterocyclic diazo component and the residue of 5-halogeno-2,3-dihydrozypyridine as coupling component CIBA-GEIGY AG (CH) 1977-01-04 US disclosed
US-4001205-A WATER-SOLUBLE, FIBER-REACTIVE PHENYLAZODIHYDROXY, METHYL, CYANOPYRIDINE DYESTUFFS CIBA-GEIGY AG (CH) 1977-01-04 US disclosed
US-3956263-A 4-Methyl-2,6-dihydroxy-3-cyanopyridine containing dyestuffs CIBA-GEIGY AG (CH) 1976-05-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160016116-A1 FORWARD OSMOSIS SYSTEM USING COORDINATION COMPLEXES SLC26A3, SLC26A4, OTC TSHR 1535/4885TP53 3317/4885CYP2C9 4809/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.